Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lerer Hippeau Acquisition Corp.LHAA · Entity 121503 | Director · Chairman · 10% owner | December 14, 2022 | December 16, 2022 |
| Strata Critical Medical, Inc.BLDE · Entity 5512 | Director | August 01, 2025 | August 05, 2025 |
| Viacom Inc.VIA, VIAB · Entity 153277 | Director | January 31, 2018 | February 02, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lerer Hippeau Acquisition Corp.
Report date December 14, 2022 · Filed December 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2022-12-14 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2022-12-14 · Other · Disposed 685,324 · Balance 0 F1: On December 14, 2022, because the Issuer had not completed a business combination by December 14, 2022, as required by its Amended and Restated Certificate of Incorporation, as amended, the Issuer redeemed all issued and outstanding public shares of Class A common stock, $0.0001 par value per share (the "Public Shares"), at a per share redemption price of $10.09143587 (the "Liquidation"). On December 13, 2022, The Nasdaq Stock Market LLC filed a Form 25 with the U.S. Securities and Exchange Commission ("SEC") to delist the Issuer's securities. As a result, the Public Shares ceased trading as of the close of business on December 13, 2022. The Issuer is expected to file a Form 15 with the SEC to terminate the registration of the securities under the Securities Exchange Act of 1934, as amended. Upon the effectiveness of the Form 15, the reporting person will cease to have a reporting obligation with respect to the Issuer's securities. F2: Reflects the cancellation by the Issuer of 685,324 shares of Class A common stock, $0.0001 par value per share, pursuant to the Liquidation. F3: The shares are held directly by the Issuer's sponsor, LHAC Sponsor LLC (the "Sponsor"). The managing member of the Sponsor is KEB II LLC, the members of which are Eric Hippeau, Kenneth Lerer and Benjamin Lerer. Each of Mssrs. Hippeau, Lerer and Lerer have joint voting and dispositive power over the shares held by the Sponsor and disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest. |
| Class B common stock, $0.0001 par value per shareSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2022-12-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-12-14 · Other · Disposed 5,566,546 · Balance 0 F4: As described in the Issuer's registration statement on Form S-1 (File No. 333-253066) under the heading "Description of Securities--Founder Shares," the shares of Class B common stock, par value $0.0001 per share, of the Issuer automatically convert into shares of Class A common stock, par value $0.0001 per share, of the Issuer upon an initial business combination of the Issuer on a one-for-one basis, subject to certain adjustments, and have no expiration date. F1: On December 14, 2022, because the Issuer had not completed a business combination by December 14, 2022, as required by its Amended and Restated Certificate of Incorporation, as amended, the Issuer redeemed all issued and outstanding public shares of Class A common stock, $0.0001 par value per share (the "Public Shares"), at a per share redemption price of $10.09143587 (the "Liquidation"). On December 13, 2022, The Nasdaq Stock Market LLC filed a Form 25 with the U.S. Securities and Exchange Commission ("SEC") to delist the Issuer's securities. As a result, the Public Shares ceased trading as of the close of business on December 13, 2022. The Issuer is expected to file a Form 15 with the SEC to terminate the registration of the securities under the Securities Exchange Act of 1934, as amended. Upon the effectiveness of the Form 15, the reporting person will cease to have a reporting obligation with respect to the Issuer's securities. F5: Reflects the cancellation by the Issuer of 5,566,546 shares of Class B common stock, $0.0001 par value per share, pursuant to the Liquidation. F3: The shares are held directly by the Issuer's sponsor, LHAC Sponsor LLC (the "Sponsor"). The managing member of the Sponsor is KEB II LLC, the members of which are Eric Hippeau, Kenneth Lerer and Benjamin Lerer. Each of Mssrs. Hippeau, Lerer and Lerer have joint voting and dispositive power over the shares held by the Sponsor and disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 14, 2022, because the Issuer had not completed a business combination by December 14, 2022, as required by its Amended and Restated Certificate of Incorporation, as amended, the Issuer redeemed all issued and outstanding public shares of Class A common stock, $0.0001 par value per share (the "Public Shares"), at a per share redemption price of $10.09143587 (the "Liquidation"). On December 13, 2022, The Nasdaq Stock Market LLC filed a Form 25 with the U.S. Securities and Exchange Commission ("SEC") to delist the Issuer's securities. As a result, the Public Shares ceased trading as of the close of business on December 13, 2022. The Issuer is expected to file a Form 15 with the SEC to terminate the registration of the securities under the Securities Exchange Act of 1934, as amended. Upon the effectiveness of the Form 15, the reporting person will cease to have a reporting obligation with respect to the Issuer's securities.
F2: Reflects the cancellation by the Issuer of 685,324 shares of Class A common stock, $0.0001 par value per share, pursuant to the Liquidation.
F3: The shares are held directly by the Issuer's sponsor, LHAC Sponsor LLC (the "Sponsor"). The managing member of the Sponsor is KEB II LLC, the members of which are Eric Hippeau, Kenneth Lerer and Benjamin Lerer. Each of Mssrs. Hippeau, Lerer and Lerer have joint voting and dispositive power over the shares held by the Sponsor and disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest.
F4: As described in the Issuer's registration statement on Form S-1 (File No. 333-253066) under the heading "Description of Securities--Founder Shares," the shares of Class B common stock, par value $0.0001 per share, of the Issuer automatically convert into shares of Class A common stock, par value $0.0001 per share, of the Issuer upon an initial business combination of the Issuer on a one-for-one basis, subject to certain adjustments, and have no expiration date.
F5: Reflects the cancellation by the Issuer of 5,566,546 shares of Class B common stock, $0.0001 par value per share, pursuant to the Liquidation.
Strata Critical Medical, Inc.
Report date August 01, 2025 · Filed August 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 165,964 |
Reported balance
After 2025-08-01 transaction · row 1
1 source rowRow 1 · 2025-08-01 · Grant · Acquired 35,534 · Balance 165,964 F1: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2026 Annual Meeting of Stockholders. |
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | IndirectSee Footnotes | 57,732 |
Reported balance
Holding disclosure · report date 2025-08-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 57,732 F2: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F3: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P. |
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | IndirectSee Footnotes | 30,895 |
Reported balance
Holding disclosure · report date 2025-08-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 30,895 F2: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F4: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2026 Annual Meeting of Stockholders.
F2: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein.
F3: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P.
F4: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P.
Viacom Inc.
Report date January 31, 2018 · Filed February 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table I · non-derivative | Direct | 4,251 |
Ending reported balance
After 2018-01-31 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-01-31 · Exercise / conversion · Acquired 4,152 · Balance 4,152 F1: These shares were issued on January 31, 2018 upon the vesting of Restricted Share Units ("RSUs") that were granted on January 31, 2017. On the date of vesting, the closing price of the Class B Common Stock on The NASDAQ Global Select Market was $33.42 per share. Row 2 · 2018-01-31 · Grant · Acquired 99 · Balance 4,251 F2: These shares were issued in respect of dividend equivalents that accrued on the RSUs prior to vesting and that were reinvested in Class B common stock upon vesting. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 5,236 |
Reported balance
After 2018-01-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-01-31 · Grant · Acquired 5,236 · Balance 5,236 F3: Granted under the Viacom Inc. 2011 RSU Plan for Outside Directors, as amended and restated as of January 1, 2016, and as further amended and restated as of October 31, 2016, for no consideration. F4: These RSUs will vest on January 31, 2019 and a corresponding number of Class B shares will be delivered on that date, unless the director has elected to defer receipt. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-01-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-01-31 · Exercise / conversion · Disposed 4,152 · Balance 0 F3: Granted under the Viacom Inc. 2011 RSU Plan for Outside Directors, as amended and restated as of January 1, 2016, and as further amended and restated as of October 31, 2016, for no consideration. F1: These shares were issued on January 31, 2018 upon the vesting of Restricted Share Units ("RSUs") that were granted on January 31, 2017. On the date of vesting, the closing price of the Class B Common Stock on The NASDAQ Global Select Market was $33.42 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were issued on January 31, 2018 upon the vesting of Restricted Share Units ("RSUs") that were granted on January 31, 2017. On the date of vesting, the closing price of the Class B Common Stock on The NASDAQ Global Select Market was $33.42 per share.
F2: These shares were issued in respect of dividend equivalents that accrued on the RSUs prior to vesting and that were reinvested in Class B common stock upon vesting.
F3: Granted under the Viacom Inc. 2011 RSU Plan for Outside Directors, as amended and restated as of January 1, 2016, and as further amended and restated as of October 31, 2016, for no consideration.
F4: These RSUs will vest on January 31, 2019 and a corresponding number of Class B shares will be delivered on that date, unless the director has elected to defer receipt.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2025 Filed Aug 5, 2025 18:14 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 35,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-25-000073 · wk-form4_1754432052.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,964 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2026 Annual Meeting of Stockholders. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 11:48 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 42,826 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-24-000105 · wk-form4_1723564133.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,430 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2025 Annual Meeting of Stockholders. Read SEC document |
| August 08, 2023 Filed Aug 9, 2023 17:29 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 31,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-23-000087 · wf-form4_169161655455861.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,604 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2024 Annual Meeting of Stockholders. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 16:05 UTC | Lerer Hippeau Acquisition Corp. LHAA · Entity 121503 | OtherClass B common stock, $0.0001 par value per share · Derivative | 5,566,546 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-038811 · doc4.xml · derivative · entry 2 LERER KENNETH B · CIK 0001120789 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A common stock, $0.0001 par value per share · 5,566,546 shares Expires not disclosed F4 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-253066) under the heading "Description of Securities--Founder Shares," the shares of Class B common stock, par value $0.0001 per share, of the Issuer automatically convert into shares of Class A common stock, par value $0.0001 per share, of the Issuer upon an initial business combination of the Issuer on a one-for-one basis, subject to certain adjustments, and have no expiration date. F1 · kind: On December 14, 2022, because the Issuer had not completed a business combination by December 14, 2022, as required by its Amended and Restated Certificate of Incorporation, as amended, the Issuer redeemed all issued and outstanding public shares of Class A common stock, $0.0001 par value per share (the "Public Shares"), at a per share redemption price of $10.09143587 (the "Liquidation"). On December 13, 2022, The Nasdaq Stock Market LLC filed a Form 25 with the U.S. Securities and Exchange Commission ("SEC") to delist the Issuer's securities. As a result, the Public Shares ceased trading as of the close of business on December 13, 2022. The Issuer is expected to file a Form 15 with the SEC to terminate the registration of the securities under the Securities Exchange Act of 1934, as amended. Upon the effectiveness of the Form 15, the reporting person will cease to have a reporting obligation with respect to the Issuer's securities. F1 · shares: On December 14, 2022, because the Issuer had not completed a business combination by December 14, 2022, as required by its Amended and Restated Certificate of Incorporation, as amended, the Issuer redeemed all issued and outstanding public shares of Class A common stock, $0.0001 par value per share (the "Public Shares"), at a per share redemption price of $10.09143587 (the "Liquidation"). On December 13, 2022, The Nasdaq Stock Market LLC filed a Form 25 with the U.S. Securities and Exchange Commission ("SEC") to delist the Issuer's securities. As a result, the Public Shares ceased trading as of the close of business on December 13, 2022. The Issuer is expected to file a Form 15 with the SEC to terminate the registration of the securities under the Securities Exchange Act of 1934, as amended. Upon the effectiveness of the Form 15, the reporting person will cease to have a reporting obligation with respect to the Issuer's securities. F5 · price: Reflects the cancellation by the Issuer of 5,566,546 shares of Class B common stock, $0.0001 par value per share, pursuant to the Liquidation. F4 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-253066) under the heading "Description of Securities--Founder Shares," the shares of Class B common stock, par value $0.0001 per share, of the Issuer automatically convert into shares of Class A common stock, par value $0.0001 per share, of the Issuer upon an initial business combination of the Issuer on a one-for-one basis, subject to certain adjustments, and have no expiration date. F4 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-253066) under the heading "Description of Securities--Founder Shares," the shares of Class B common stock, par value $0.0001 per share, of the Issuer automatically convert into shares of Class A common stock, par value $0.0001 per share, of the Issuer upon an initial business combination of the Issuer on a one-for-one basis, subject to certain adjustments, and have no expiration date. F3 · ownership.nature: The shares are held directly by the Issuer's sponsor, LHAC Sponsor LLC (the "Sponsor"). The managing member of the Sponsor is KEB II LLC, the members of which are Eric Hippeau, Kenneth Lerer and Benjamin Lerer. Each of Mssrs. Hippeau, Lerer and Lerer have joint voting and dispositive power over the shares held by the Sponsor and disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 16:05 UTC | Lerer Hippeau Acquisition Corp. LHAA · Entity 121503 | OtherClass A common stock, $0.0001 par value per share | 685,324 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-038811 · doc4.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: On December 14, 2022, because the Issuer had not completed a business combination by December 14, 2022, as required by its Amended and Restated Certificate of Incorporation, as amended, the Issuer redeemed all issued and outstanding public shares of Class A common stock, $0.0001 par value per share (the "Public Shares"), at a per share redemption price of $10.09143587 (the "Liquidation"). On December 13, 2022, The Nasdaq Stock Market LLC filed a Form 25 with the U.S. Securities and Exchange Commission ("SEC") to delist the Issuer's securities. As a result, the Public Shares ceased trading as of the close of business on December 13, 2022. The Issuer is expected to file a Form 15 with the SEC to terminate the registration of the securities under the Securities Exchange Act of 1934, as amended. Upon the effectiveness of the Form 15, the reporting person will cease to have a reporting obligation with respect to the Issuer's securities. F1 · shares: On December 14, 2022, because the Issuer had not completed a business combination by December 14, 2022, as required by its Amended and Restated Certificate of Incorporation, as amended, the Issuer redeemed all issued and outstanding public shares of Class A common stock, $0.0001 par value per share (the "Public Shares"), at a per share redemption price of $10.09143587 (the "Liquidation"). On December 13, 2022, The Nasdaq Stock Market LLC filed a Form 25 with the U.S. Securities and Exchange Commission ("SEC") to delist the Issuer's securities. As a result, the Public Shares ceased trading as of the close of business on December 13, 2022. The Issuer is expected to file a Form 15 with the SEC to terminate the registration of the securities under the Securities Exchange Act of 1934, as amended. Upon the effectiveness of the Form 15, the reporting person will cease to have a reporting obligation with respect to the Issuer's securities. F2 · price: Reflects the cancellation by the Issuer of 685,324 shares of Class A common stock, $0.0001 par value per share, pursuant to the Liquidation. F3 · ownership.nature: The shares are held directly by the Issuer's sponsor, LHAC Sponsor LLC (the "Sponsor"). The managing member of the Sponsor is KEB II LLC, the members of which are Eric Hippeau, Kenneth Lerer and Benjamin Lerer. Each of Mssrs. Hippeau, Lerer and Lerer have joint voting and dispositive power over the shares held by the Sponsor and disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 16:49 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 8,376 | $6.27 | $52,487.37 |
DisclosureSEC source: 0001779128-22-000089 · wf-form4_166076930057845.xml · nonDerivative · entry 4 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 30,895 F5 · price: These transactions were executed in multiple trades at prices ranging from $6.25 to $6.305, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F4 · ownership.nature: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 16:49 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 15,654 | $6.27 | $98,094.23 |
DisclosureSEC source: 0001779128-22-000089 · wf-form4_166076930057845.xml · nonDerivative · entry 3 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 57,732 F5 · price: These transactions were executed in multiple trades at prices ranging from $6.25 to $6.305, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F3 · ownership.nature: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 16:49 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 13,883 | $6.34 | $88,014.06 |
DisclosureSEC source: 0001779128-22-000089 · wf-form4_166076930057845.xml · nonDerivative · entry 2 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 39,271 F1 · price: These transactions were executed in multiple trades at prices ranging from $6.25 to $6.64, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F4 · ownership.nature: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 16:49 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 25,943 | $6.34 | $164,470.84 |
DisclosureSEC source: 0001779128-22-000089 · wf-form4_166076930057845.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 73,386 F1 · price: These transactions were executed in multiple trades at prices ranging from $6.25 to $6.64, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F3 · ownership.nature: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P. Read SEC document |
| August 12, 2022 Filed Aug 15, 2022 10:28 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 89,896 | $6.51 | $585,267.91 |
DisclosureSEC source: 0001779128-22-000085 · wf-form4_166057367882020.xml · nonDerivative · entry 4 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 99,329 F5 · price: These transactions were executed in multiple trades at prices ranging from $6.31 to $6.65, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F4 · ownership.nature: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P. Read SEC document |
| August 12, 2022 Filed Aug 15, 2022 10:28 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 48,104 | $6.51 | $313,181.09 |
DisclosureSEC source: 0001779128-22-000085 · wf-form4_166057367882020.xml · nonDerivative · entry 3 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 53,154 F5 · price: These transactions were executed in multiple trades at prices ranging from $6.31 to $6.65, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P. F3 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 10:28 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 82,079 | $6.42 | $527,103.13 |
DisclosureSEC source: 0001779128-22-000085 · wf-form4_166057367882020.xml · nonDerivative · entry 2 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 189,225 F1 · price: These transactions were executed in multiple trades at prices ranging from $6.27 to $6.82, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F4 · ownership.nature: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 10:28 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 43,921 | $6.42 | $282,056.27 |
DisclosureSEC source: 0001779128-22-000085 · wf-form4_166057367882020.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 101,258 F1 · price: These transactions were executed in multiple trades at prices ranging from $6.27 to $6.82, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P. F3 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. Read SEC document |
| June 06, 2022 Filed Jun 6, 2022 17:13 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 12,195 | $7.03 | $85,715.00 |
DisclosureSEC source: 0001779128-22-000059 · primary_doc.xml · nonDerivative · entry 4 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 145,179 F5 · price: These transactions were executed in multiple trades at prices ranging from $7.00 to $7.16, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F4 · ownership.nature: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P. Read SEC document |
| June 06, 2022 Filed Jun 6, 2022 17:13 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 22,789 | $7.03 | $160,177.04 |
DisclosureSEC source: 0001779128-22-000059 · primary_doc.xml · nonDerivative · entry 3 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 271,305 F5 · price: These transactions were executed in multiple trades at prices ranging from $7.00 to $7.16, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F3 · ownership.nature: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 17:13 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 11,114 | $7.08 | $78,646.00 |
DisclosureSEC source: 0001779128-22-000059 · primary_doc.xml · nonDerivative · entry 2 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 157,374 F1 · price: These transactions were executed in multiple trades at prices ranging from $7.00 to $7.29, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F4 · ownership.nature: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 17:13 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 20,771 | $7.08 | $146,981.83 |
DisclosureSEC source: 0001779128-22-000059 · primary_doc.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 294,094 F1 · price: These transactions were executed in multiple trades at prices ranging from $7.00 to $7.29, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F3 · ownership.nature: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P. Read SEC document |
| June 02, 2022 Filed Jun 2, 2022 18:59 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 80,780 | $7.34 | $592,763.64 |
DisclosureSEC source: 0000899243-22-020767 · doc4.xml · nonDerivative · entry 6 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 168,488 F6 · price: These transactions were executed in multiple trades at prices ranging from $7.03 to $7.45, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F4 · ownership.nature: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P. Read SEC document |
| June 02, 2022 Filed Jun 2, 2022 18:59 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 150,961 | $7.34 | $1,107,751.82 |
DisclosureSEC source: 0000899243-22-020767 · doc4.xml · nonDerivative · entry 5 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 314,865 F6 · price: These transactions were executed in multiple trades at prices ranging from $7.03 to $7.45, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F3 · ownership.nature: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 18:59 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 694 | $7.01 | $4,867.72 |
DisclosureSEC source: 0000899243-22-020767 · doc4.xml · nonDerivative · entry 4 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 249,268 F5 · price: These transactions were executed in multiple trades at prices ranging from $7.000 to $7.045, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F4 · ownership.nature: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 18:59 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 1,297 | $7.01 | $9,097.16 |
DisclosureSEC source: 0000899243-22-020767 · doc4.xml · nonDerivative · entry 3 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 465,826 F5 · price: These transactions were executed in multiple trades at prices ranging from $7.000 to $7.045, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F3 · ownership.nature: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 18:59 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 16,582 | $7.06 | $117,085.50 |
DisclosureSEC source: 0000899243-22-020767 · doc4.xml · nonDerivative · entry 2 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 249,962 F1 · price: These transactions were executed in multiple trades at prices ranging from $7.00 to $7.18, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F4 · ownership.nature: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 18:59 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 30,989 | $7.06 | $218,813.33 |
DisclosureSEC source: 0000899243-22-020767 · doc4.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 467,123 F1 · price: These transactions were executed in multiple trades at prices ranging from $7.00 to $7.18, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F3 · ownership.nature: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P. Read SEC document |
| May 26, 2022 Filed May 27, 2022 18:45 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 78,593 | $7.01 | $550,858.34 |
DisclosureSEC source: 0000899243-22-019994 · doc4.xml · nonDerivative · entry 8 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 266,544 F7 · price: These transactions were executed in multiple trades at prices ranging from $6.915 to $7.240, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F5 · ownership.nature: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P. Read SEC document |
| May 26, 2022 Filed May 27, 2022 18:45 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 146,873 | $7.01 | $1,029,432.86 |
DisclosureSEC source: 0000899243-22-019994 · doc4.xml · nonDerivative · entry 7 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 498,112 F7 · price: These transactions were executed in multiple trades at prices ranging from $6.915 to $7.240, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F4 · ownership.nature: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P. Read SEC document |
| May 26, 2022 Filed May 27, 2022 18:45 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 47,029 | $7.03 | $330,660.90 |
DisclosureSEC source: 0000899243-22-019994 · doc4.xml · nonDerivative · entry 5 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,426 F6 · price: These transactions were executed in multiple trades at prices ranging from $7.00 to $7.20, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 25, 2022 Filed May 27, 2022 18:45 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 102,898 | $7.03 | $723,475.84 |
DisclosureSEC source: 0000899243-22-019994 · doc4.xml · nonDerivative · entry 6 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F6 · price: These transactions were executed in multiple trades at prices ranging from $7.00 to $7.20, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F3 · ownership.nature: Held directly by Lerer Investments II, LLC. Kenneth Lerer is Managing Member of Lerer Investments II, LLC. Read SEC document |
| May 25, 2022 Filed May 27, 2022 18:45 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 28,851 | $7.11 | $205,101.76 |
DisclosureSEC source: 0000899243-22-019994 · doc4.xml · nonDerivative · entry 4 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 345,137 F1 · price: These transactions were executed in multiple trades at prices ranging from $7.01 to $7.21, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F5 · ownership.nature: Held directly by Lerer Hippeau Ventures Select Fund, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures Select Fund GP, LLC, the general partner of Lerer Hippeau Ventures Select Fund, L.P. Read SEC document |
| May 25, 2022 Filed May 27, 2022 18:45 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 53,916 | $7.11 | $383,288.84 |
DisclosureSEC source: 0000899243-22-019994 · doc4.xml · nonDerivative · entry 3 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 644,985 F1 · price: These transactions were executed in multiple trades at prices ranging from $7.01 to $7.21, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F4 · ownership.nature: Held directly by Lerer Hippeau Ventures V, LP. Kenneth Lerer is the Managing Member of Lerer Hippeau Ventures V GP, LLC, the general partner of Lerer Hippeau Ventures V, L.P. Read SEC document |
| May 25, 2022 Filed May 27, 2022 18:45 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 8,602 | $7.11 | $61,151.62 |
DisclosureSEC source: 0000899243-22-019994 · doc4.xml · nonDerivative · entry 2 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 102,898 F1 · price: These transactions were executed in multiple trades at prices ranging from $7.01 to $7.21, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Kenneth Lerer disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. F3 · ownership.nature: Held directly by Lerer Investments II, LLC. Kenneth Lerer is Managing Member of Lerer Investments II, LLC. Read SEC document |
| May 25, 2022 Filed May 27, 2022 18:45 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 3,931 | $7.11 | $27,945.48 |
DisclosureSEC source: 0000899243-22-019994 · doc4.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,455 F1 · price: These transactions were executed in multiple trades at prices ranging from $7.01 to $7.21, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 18, 2022 Filed May 19, 2022 13:45 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 11,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-22-000051 · wf-form4_165298231717402.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,386 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting: 25% of the RSUs (rounded down to the nearest whole number) to become vested every three months measured from May 7, 2022, with the remainder to become vested on May 7, 2023, such that the RSUs become 100% vested on May 7, 2023. Read SEC document |
| August 20, 2021 Filed Aug 20, 2021 17:59 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 45,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-007850 · form4.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,982 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 12,863 of the RSUs will vest on a basis of 25% each three months measured from May 7, 2021, subject to the Reporting Person's continued service to the Company through the applicable vesting date or the end of the Reporting Person's current term as a director of the Issuer. The remaining RSUs will vest on May 7, 2023, subject to the Reporting Person's continued service to the Issuer through the earlier of (i) the end of the Reporting Person's current term as a director and (ii) May 7, 2023. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 16:09 UTC | Lerer Hippeau Acquisition Corp. LHAA · Entity 121503 | OtherClass B common stock, $0.0001 par value per share · Derivative | 183,454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-21-002602 · form4.xml · derivative · entry 2 LERER KENNETH B · CIK 0001120789 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,566,546 Underlying: Class A common stock, $0.0001 par value per share · 183,454 shares Expires not disclosed F3 · derivative.exercise_price: As described in the issuer's registration statement on Form S-1 (File No. 333-253066) under the heading "Description of Securities--Founder Shares," the shares of Class B common stock, par value $0.0001 per share, of the issuer will automatically convert into shares of Class A common stock, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments, and have no expiration date. F4 · kind: Reflects the cancellation by the issuer of 183,454 shares of Class B common stock, $0.0001 par value per share, which were automatically surrendered to the issuer for no consideration by the reporting person pursuant to contractual arrangements with the issuer, triggered by the election by the underwriters of the issuer's initial public offering to partially exercise their option to purchase additional shares and surrender their right to purchase the remainder of the option shares. F4 · price: Reflects the cancellation by the issuer of 183,454 shares of Class B common stock, $0.0001 par value per share, which were automatically surrendered to the issuer for no consideration by the reporting person pursuant to contractual arrangements with the issuer, triggered by the election by the underwriters of the issuer's initial public offering to partially exercise their option to purchase additional shares and surrender their right to purchase the remainder of the option shares. F3 · derivative.exercise_date: As described in the issuer's registration statement on Form S-1 (File No. 333-253066) under the heading "Description of Securities--Founder Shares," the shares of Class B common stock, par value $0.0001 per share, of the issuer will automatically convert into shares of Class A common stock, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments, and have no expiration date. F3 · derivative.expiration_date: As described in the issuer's registration statement on Form S-1 (File No. 333-253066) under the heading "Description of Securities--Founder Shares," the shares of Class B common stock, par value $0.0001 per share, of the issuer will automatically convert into shares of Class A common stock, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments, and have no expiration date. F2 · ownership.nature: The shares are held directly by the issuer's sponsor, LHAC Sponsor LLC (the "Sponsor"). The managing member of the Sponsor is KEB II LLC, the members of which are Eric Hippeau, Kenneth Lerer and Benjamin Lerer. Each of Mssrs. Hippeau, Lerer and Lerer have joint voting and dispositive power over the shares held by the Sponsor and disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 16:09 UTC | Lerer Hippeau Acquisition Corp. LHAA · Entity 121503 | PurchaseClass A common stock, $0.0001 par value per share | 45,324 | $10.00 | $453,240.00 |
DisclosureSEC source: 0001062993-21-002602 · form4.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 685,324 F1 · shares: Additional shares of Class A common stock, par value $0.0001 per share, purchased by the reporting person in a private placement concurrently with the issuer's initial public offering, in connection with the underwriters' partial exercise of its over-allotment option. F2 · ownership.nature: The shares are held directly by the issuer's sponsor, LHAC Sponsor LLC (the "Sponsor"). The managing member of the Sponsor is KEB II LLC, the members of which are Eric Hippeau, Kenneth Lerer and Benjamin Lerer. Each of Mssrs. Hippeau, Lerer and Lerer have joint voting and dispositive power over the shares held by the Sponsor and disclaim beneficial ownership over any securities owned by the Sponsor in which they do not have any pecuniary interest. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 16:55 UTC | Viacom Inc. VIA, VIAB · Entity 153277 | Exercise / conversionRestricted Share Units · Derivative | 4,152 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006961 · doc4.xml · derivative · entry 4 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 4,152 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted under the Viacom Inc. 2011 RSU Plan for Outside Directors, as amended and restated as of January 1, 2016, and as further amended and restated as of October 31, 2016, for no consideration. F1 · derivative.exercise_price: These shares were issued on January 31, 2018 upon the vesting of Restricted Share Units ("RSUs") that were granted on January 31, 2017. On the date of vesting, the closing price of the Class B Common Stock on The NASDAQ Global Select Market was $33.42 per share. F3 · price: Granted under the Viacom Inc. 2011 RSU Plan for Outside Directors, as amended and restated as of January 1, 2016, and as further amended and restated as of October 31, 2016, for no consideration. F1 · derivative.exercise_date: These shares were issued on January 31, 2018 upon the vesting of Restricted Share Units ("RSUs") that were granted on January 31, 2017. On the date of vesting, the closing price of the Class B Common Stock on The NASDAQ Global Select Market was $33.42 per share. F1 · derivative.expiration_date: These shares were issued on January 31, 2018 upon the vesting of Restricted Share Units ("RSUs") that were granted on January 31, 2017. On the date of vesting, the closing price of the Class B Common Stock on The NASDAQ Global Select Market was $33.42 per share. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 16:55 UTC | Viacom Inc. VIA, VIAB · Entity 153277 | GrantRestricted Share Units · Derivative | 5,236 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006961 · doc4.xml · derivative · entry 3 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,236 Underlying: Class B Common Stock · 5,236 shares Expires not disclosed F3 · security: Granted under the Viacom Inc. 2011 RSU Plan for Outside Directors, as amended and restated as of January 1, 2016, and as further amended and restated as of October 31, 2016, for no consideration. F4 · derivative.exercise_price: These RSUs will vest on January 31, 2019 and a corresponding number of Class B shares will be delivered on that date, unless the director has elected to defer receipt. F3 · price: Granted under the Viacom Inc. 2011 RSU Plan for Outside Directors, as amended and restated as of January 1, 2016, and as further amended and restated as of October 31, 2016, for no consideration. F4 · derivative.exercise_date: These RSUs will vest on January 31, 2019 and a corresponding number of Class B shares will be delivered on that date, unless the director has elected to defer receipt. F4 · derivative.expiration_date: These RSUs will vest on January 31, 2019 and a corresponding number of Class B shares will be delivered on that date, unless the director has elected to defer receipt. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 16:55 UTC | Viacom Inc. VIA, VIAB · Entity 153277 | GrantClass B Common Stock | 99 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006961 · doc4.xml · nonDerivative · entry 2 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,251 F2 · shares: These shares were issued in respect of dividend equivalents that accrued on the RSUs prior to vesting and that were reinvested in Class B common stock upon vesting. F2 · price: These shares were issued in respect of dividend equivalents that accrued on the RSUs prior to vesting and that were reinvested in Class B common stock upon vesting. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 16:55 UTC | Viacom Inc. VIA, VIAB · Entity 153277 | Exercise / conversionClass B Common Stock | 4,152 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006961 · doc4.xml · nonDerivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were issued on January 31, 2018 upon the vesting of Restricted Share Units ("RSUs") that were granted on January 31, 2017. On the date of vesting, the closing price of the Class B Common Stock on The NASDAQ Global Select Market was $33.42 per share. F1 · price: These shares were issued on January 31, 2018 upon the vesting of Restricted Share Units ("RSUs") that were granted on January 31, 2017. On the date of vesting, the closing price of the Class B Common Stock on The NASDAQ Global Select Market was $33.42 per share. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 16:18 UTC | Viacom Inc. VIA, VIAB · Entity 153277 | GrantRestricted Share Units · Derivative | 4,152 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-007081 · doc4.xml · derivative · entry 1 LERER KENNETH B · CIK 0001120789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,152 Underlying: Class B Common Stock · 4,152 shares Expires not disclosed F1 · security: Granted under the Viacom Inc. 2011 RSU Plan for Outside Directors, as amended and restated as of January 1, 2016, and as further amended and restated as of October 31, 2016, for no consideration. F2 · derivative.exercise_price: These Restricted Share Units will vest on January 31, 2018 and a corresponding number of Class B shares will be delivered on that date, unless the director has elected to defer receipt. F1 · price: Granted under the Viacom Inc. 2011 RSU Plan for Outside Directors, as amended and restated as of January 1, 2016, and as further amended and restated as of October 31, 2016, for no consideration. F2 · derivative.exercise_date: These Restricted Share Units will vest on January 31, 2018 and a corresponding number of Class B shares will be delivered on that date, unless the director has elected to defer receipt. F2 · derivative.expiration_date: These Restricted Share Units will vest on January 31, 2018 and a corresponding number of Class B shares will be delivered on that date, unless the director has elected to defer receipt. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.